Mitochondrial Calcium Ion Nanogluttons Alleviate Periodontitis via Controlling mPTPs

Author:

He Ping1ORCID,Liu Fengyi234,Li Mingzheng234,Ren Mingxing1,Wang Xu1,Deng Yangjia1,Wu Xianghao1,Li Yuzhou234,Yang Sheng234,Song Jinlin234ORCID

Affiliation:

1. College of Stomatology Chongqing Medical University Chongqing 401147 China

2. Stomatological Hospital of Chongqing Medical University Chongqing 401147 China

3. Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences Chongqing 401147 China

4. Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education Chongqing 401147 China

Abstract

AbstractThe mitochondrial permeability transition (mPT) directly affects mitochondrial function in macrophages. Under inflammatory conditions, mitochondrial calcium ion (mitoCa2+) overload triggers the persistent opening of mPT pores (mPTPs), further aggravating Ca2+ overload and increasing reactive oxygen species (ROS) to form an adverse cycle. However, there are currently no effective drugs targeting mPTPs to confine or unload excess Ca2+. It is novelly demonstrated that the initiation of periodontitis and the activation of proinflammatory macrophages depend on the persistent overopening of mPTPs, which is mainly triggered by mitoCa2+ overload and facilitates further mitochondrial ROS leakage into the cytoplasm. To solve the above problems, mitochondrial‐targeted “nanogluttons” with PEG‐TPP conjugated to the surface of PAMAM and BAPTA‐AM encapsulated in the core are designed. These nanogluttons can efficiently “glut” Ca2+ around and inside mitochondria to effectively control the sustained opening of mPTPs. As a result, the nanogluttons significantly inhibit the inflammatory activation of macrophages. Further studies also unexpectedly reveal that the alleviation of local periodontal inflammation in mice is accompanied by diminished osteoclast activity and reduced bone loss. This provides a promising strategy for mitochondria‐targeted intervention in inflammatory bone loss in periodontitis and can be extended to treat other chronic inflammatory diseases associated with mitoCa2+ overload.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Chongqing

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3